Comparative Impacts of ACE (Angiotensin-Converting Enzyme) Inhibitors Versus Angiotensin II Receptor Blockers on the Risk of COVID-19 Mortality
Feng Zhou, Ye-Mao Liu, Jing Xie, Haomiao Li, Fang Lei, Huilin Yang, Juan‐Juan Qin, Jingjing Cai, Xiao-Jing Zhang, Bin Wu, Xia Meng, Xiang Da, Chengzhang Yang, Xinliang Ma, Qingbo Xu, Zhigang Lu, Haofeng Lu, Xigang Xia, Daihong Wang, Xiaofeng Liao, Gang Peng, Jun Yang, Xiaodong Huang, Bing-Hong Zhang, Yufeng Yuan, Wei Xiang, Peter P. Liu, Yibin Wang, Peng Zhang, Zhi‐Gang She, Jiahong Xia, Hongliang Li
Topics & Concepts
Angiotensin Receptor BlockersAngiotensin-converting enzymeInternal medicineAngiotensin IIAngiotensin-converting enzyme 2MedicineCoronavirus disease 2019 (COVID-19)ReceptorBlood pressureInfectious disease (medical specialty)DiseaseCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchCOVID-19 and Mental Health